Understanding the factors that increase or reduce costs and the ways that payments affect the choices people make can help improve health and health care decision making.
Lack of data regarding dual-eligible individuals has long hindered the development of effective policy solutions and care improvement. AcademyHealth organizational member Arnold Ventures highlights new resources to help the research community strengthen and expand evidence at a critical time in the policy debate.
As lead clinicians for their states with responsibility for overseeing clinical care and stewardship of resources, Medicaid Medical Directors share their perspectives on clinical matters related to the FDA’s Accelerated Approval Program.
A recent literature review revealed most studies of social need interventions were poorly designed, inadequately documented, and inconsistently presented. In this post, Robert Dubois of the National Pharmaceutical Council, an AcademyHealth Organizational Member, outlines the state of the research and provides recommendations to improve study design quality.
Understanding the economic impact of health interventions is critical for developing effective programs that can be replicated in different settings. At the 13th Annual Conference on the Science of Dissemination and Implementation in Health, experts shared their top tips about evaluating the economics of a new or existing initiative.
A new study published in HSR, an official journal of AcademyHealth, found that urgent care centers reduce costly emergency department (ED) visits, especially in areas with long ED wait times as well as among Medicaid enrollees and the uninsured.
This ‘plain language summary’ considers a recent commentary from Zirui Song, M.D., Ph.D., in HSR, an official journal of AcademyHealth, that offers a broad review of the state of the science on Accountable Care Organizations, including a brief discussion of three new studies also published in the August issue.
The population dually eligible for Medicare and Medicaid was one of the hardest hit by COVID-19. Arielle Mir of Arnold Ventures, an AcademyHealth organizational member, explains how policymakers are urgently seeking solutions to improve their care and experience, but better data infrastructure and research are needed to achieve meaningful change.
As the Annual Research Meeting draws to a close, this final post in our series highlighting how AcademyHealth is #MoreThanAMeeting describes our year-round work with several learning networks.
A new study published in HSR, an official journal of AcademyHealth, found that while the use of new cancer therapies did result in noteworthy improvements in lung cancer survival rates, Medicare spending increased substantially, raising concerns about the financial burden of these treatments.
In a recent webinar in collaboration with the National Pharmaceutical Council, experts discussed how to evaluate SDOH programs and interventions from a cost perspective. Speakers emphasized the incomplete state of current knowledge and the need to improve studies and data infrastructure to determine their value.
